ISSN 1674-3865  CN 21-1569/R
主管：国家卫生健康委员会
主办：中国医师协会
　　　辽宁省基础医学研究所
　　　辽宁中医药大学附属医院
中国中西医结合儿科学

中国中西医结合儿科学 ›› 2018, Vol. 10 ›› Issue (4): 330-333.doi: 10.3969/j.issn.1674-3865.2018.04.017

• 临床研究 • 上一篇    下一篇

泻白散加味治疗小儿肺热型便秘临床疗效观察

王海俊，周鸿雲，赵琼，罗雅婷，潜鸣   

  1. 610075 成都，成都中医药大学附属医院儿科（王海俊）；成都中医药大学临床医学院（周鸿雲，赵琼，罗雅婷，潜鸣）
  • 出版日期:2018-08-25 发布日期:2018-12-03
  • 通讯作者: 周鸿雲，E-mail：echohongyun@163.com
  • 作者简介:王海俊（1978-），男，医学硕士，主治医师。研究方向：小儿过敏性紫癜、肾病综合征的诊治

Clinical Observation on treatment for constipation with lung-heat in children by modified Xiebai powder

WANG Haijun，ZHOU Hongyun，ZHAO Qiong， LUO Yating，QIAN Ming   

  1.  Department of Pediatrics，Affiliated Hospital of Chengdu University of Traditional Chinese Medicine，Chengdu 610075，China
  • Online:2018-08-25 Published:2018-12-03

PDF (PC)

60

摘要：
目的
观察验方泻白散加味治疗小儿便秘(肺热型)的临床疗效。
方法
选择2014年1月至12月成都中医药大学附属医院收治的功能性便秘患儿60例为研究对象，随机分为观察组和对照组各30例。观察组予以中药汤剂泻白散加味口服治疗，对照组予以中成药麻子仁丸口服治疗，两组均配合基础治疗，疗程2周。
结果
观察组临床疗效显著高于对照组，差异有统计学意义（P<0.01）。两组治疗后中医证候主证和次症量化积分均低于治疗前，差异有统计学意义(P<0.05)；治疗后观察组中医证候主症及次症量化积分均低于对照组，差异有统计学意义(P<0.05)。
结论
泻白散加味治疗小儿肺热型便秘临床疗效确切，值得临床推广。

关键词: 功能性便秘, 泻白散加味, 肺热型, 儿童

Abstract:
Objective
To observe the clinical efficacy of the prescription, modified Xiebai powder, in the treatment of constipation(lungheat) in children.
Methods
Sixty patients with functional constipation treated in the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine from January to December 2014 were enrolled in the study. They were randomly divided into observation group and control group(30 in each). The observation group was treated with traditional Chinese medicine decoction, modified Xiebai powder, and the control group was treated with Chinese patent medicine, Maziren pill. The two groups also received basic treatment. The treatment lasted for 2 weeks.
Results
The clinical efficacy of the observation group was significantly higher than that of the control group, and the difference was statistically significant (P<0.01). After treatment, the scores of TCM primary syndrome and secondary syndrome of two groups were lower than those before treatment, and the difference was statistically significant (P<0.05). After treatment, the scores of TCM primary syndromes and secondary syndromes in the observation group were lower than those in the control group, and the difference was statistically significant (P<0.05).
Conclusion
The clinical efficacy of modified Xiebai powder in the treatment of pulmonary heat constipation(lungheat) in children is significant, which is worthy of clinical promotion.

Key words: Functional constipation, Modified Xiebai powder, Lung-heat syndrome, Children